Atlas Trials

Drugs for the Treatment of Multiple Sclerosis and Risk of Cancer: a Pharmacovigilance Analysis in Vigibase

Clinical trial NCT04237337 · UNKNOWN

Trial details

NCT number
NCT04237337
Sponsor
University Hospital, Caen
Status
UNKNOWN
Study type
OBSERVATIONAL
Multiple SclerosisMalignant Tumor
Start date
2020-01-01
Primary completion
2020-02-01
Enrollment
200000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.